Health technology company Avita Medical has submitted a pre-market approval application to the US Food and Drug Administration for its ReCell regenerative medicine technology.
28/09/2017 - 14:28
Avita seeks US market pre-approval
28/09/2017 - 14:28
Related Data & Insights
-
-
Rank Company Revenue th Avita Medical $87.8m 1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
01 Mar 2024
Appointments March 1, 2024
22 Feb 2024
Orthocell to tap investors for $3.5m
19 Jan 2024
Appointments January 19, 2024
15 Jan 2024
Beazley joins biotech board
05 Jan 2024
Uni bootcamp nurtures medtech startup culture
04 Dec 2023
Med research’s $2.1bn potential for WA economy
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX